These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8878548)

  • 1. Multiple forms of tRNA(Lys3) in HIV-1.
    Li Z; Shalom A; Huang Y; Mak J; Arts E; Wainberg MA; Kleiman L
    Biochem Biophys Res Commun; 1996 Oct; 227(2):530-40. PubMed ID: 8878548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring three-dimensional structures of the HIV-1 RNA/tRNALys3 initiation complex.
    Elgavish T; VanLoock MS; Harvey SC
    J Mol Biol; 1999 Jan; 285(2):449-53. PubMed ID: 9878419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. tRNA(Lys3): the primer tRNA for reverse transcription in HIV-1.
    Kleiman L
    IUBMB Life; 2002 Feb; 53(2):107-14. PubMed ID: 12049192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The connection domain in reverse transcriptase facilitates the in vivo annealing of tRNALys3 to HIV-1 genomic RNA.
    Cen S; Niu M; Kleiman L
    Retrovirology; 2004 Oct; 1():33. PubMed ID: 15494076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of reverse transcriptase sequences in Pol with Gag and LysRS in the HIV-1 tRNALys3 packaging/annealing complex.
    Saadatmand J; Guo F; Cen S; Niu M; Kleiman L
    Virology; 2008 Oct; 380(1):109-17. PubMed ID: 18708237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural constraints in the HIV-1 reverse transcriptase-primer/template complex for the initiation of DNA synthesis from primer tRNALys3.
    Zakharova OD; Martiyanov IV; Timofeeva OA; Kolocheva TI; Fournier M; Andreola ML; Maksakova GA; Yamkovoy VI; Litvak S; Tarrago-Litvak L; Nevinsky GA
    Biochemistry; 1998 Sep; 37(38):13343-8. PubMed ID: 9748342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-linking localization of a HIV-1 reverse transcriptase peptide involved in the binding of primer tRNALys3.
    Dufour E; Reinbolt J; Castroviejo M; Ehresmann B; Litvak S; Tarrago-Litvak L; Andreola ML
    J Mol Biol; 1999 Jan; 285(4):1339-46. PubMed ID: 9917377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of human immunodeficiency virus type 1 reverse transcriptase primer tRNA binding by fluorescence spectroscopy: specificity and comparison to primer/template binding.
    Thrall SH; Reinstein J; Wöhrl BM; Goody RS
    Biochemistry; 1996 Apr; 35(14):4609-18. PubMed ID: 8605212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse transcriptase is an important factor for the primer tRNA selection in HIV-1.
    Jiang M; Mak J; Huang Y; Kleiman L
    Leukemia; 1994 Apr; 8 Suppl 1():S149-51. PubMed ID: 7512177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for analysis of incorporation and annealing methods for analysis of tRNA(Lys) in HIV-1.
    Cen S; Guo F; Kleiman L
    Methods Mol Biol; 2009; 485():223-32. PubMed ID: 19020829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspects of HIV-1 assembly that promote primer tRNA(Lys3) annealing to viral RNA.
    Saadatmand J; Kleiman L
    Virus Res; 2012 Nov; 169(2):340-8. PubMed ID: 22698876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended Interactions between HIV-1 Viral RNA and tRNA
    Gremminger T; Song Z; Ji J; Foster A; Weng K; Heng X
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective packaging and annealing of primer tRNALys3 in HIV-1.
    Kleiman L; Halwani R; Javanbakht H
    Curr HIV Res; 2004 Apr; 2(2):163-75. PubMed ID: 15078180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primer selection by HIV-1 reverse transcriptase on RNA-tRNA(3Lys) and DNA-tRNA(3Lys) hybrids.
    Yusupova G; Lanchy JM; Yusupov M; Keith G; Le Grice SF; Ehresmann C; Ehresmann B; Marquet R
    J Mol Biol; 1996 Aug; 261(3):315-21. PubMed ID: 8780773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV-1 replication in vitro and in human infected cells by modified antisense oligonucleotides targeting the tRNALys3/RNA initiation complex.
    Freund F; Boulmé F; Michel J; Ventura M; Moreau S; Litvak S
    Antisense Nucleic Acid Drug Dev; 2001 Oct; 11(5):301-15. PubMed ID: 11763347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable tRNA content in HIV-1IIIB.
    Jiang M; Mak J; Wainberg MA; Parniak MA; Cohen E; Kleiman L
    Biochem Biophys Res Commun; 1992 Jun; 185(3):1005-15. PubMed ID: 1627125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His).
    Zhang Z; Kang SM; LeBlanc A; Hajduk SL; Morrow CD
    Virology; 1996 Dec; 226(2):306-17. PubMed ID: 8955050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 reverse transcriptase shows no specificity for the binding of primer tRNA(Lys3).
    Arion D; Harada R; Li X; Wainberg MA; Parniak MA
    Biochem Biophys Res Commun; 1996 Aug; 225(3):839-43. PubMed ID: 8780699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tRNALys packaging complex in HIV-1.
    Kleiman L; Cen S
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1776-86. PubMed ID: 15183344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 reverse transcription initiation: a potential target for novel antivirals?
    Abbink TE; Berkhout B
    Virus Res; 2008 Jun; 134(1-2):4-18. PubMed ID: 18255184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.